Although the predictive value of bio-ADM on mortality was fair at best, these results and the strong association with the need for renal replacement therapy indicate that adrenomedullin has a role in COVID-19 pathophysiology and measuring adrenomedullin levels could aid in predicting who will develop severe disease and multi-organ failure. Here, ADM is linked to COVID-19.